Application of clinical bioinformatics in lung cancer-specific biomarkers
- 627 Downloads
The fact that lung cancer is a heterogeneous disease suggests that there is a high likelihood that effective lung cancer biomarkers will need to address patient-specific molecular defects, clinical characters, and aspects of the tumor microenvironment. In this transition, clinical bioinformatics tools and resources are the most appropriate means to improve the analysis, as major biological databases are now containing clinical data alongside genomics, proteomics, and other biological data. Clinical bioinformatics comprises a series of concepts and approaches that have been used successfully both to delineate novel biological mechanisms and to drive translational advances in individualized healthcare. In this article, we outline several of emerging clinical bioinformatics-based strategies as they apply specifically to lung cancer.
KeywordsClinical bioinformatics Lung cancer Biomarkers Network
This work was supported by the National Natural Science Foundation of China (81100534,91230204, 81270099, 81320108001, 81270131, 81300010), the Shanghai Rising Star Program (13QA1400800). The work was also supported by Zhongshan Distinguished Professor Grant (XDW), The Shanghai Committee of Science and Technology (12JC1402200, 12431900207, 11410708600, 14431905100), Zhejiang Provincial Natural Science Foundation (Z2080988), Zhejiang Provincial Science Technology Department Foundation (2010C14011), and Ministry of Education, Academic Special Science and Research Foundation for PhD Education (20130071110043). The authors have no commercial or other associations that might pose a conflict of interest in connection with the submitted material.
- 1.Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90.Google Scholar
- 17.Nishino, M., Jackman, D. M., Hatabu, H., Yeap, B. Y., Cioffredi, L. A., Yap, J. T., et al. (2010). New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR. American Journal of Roentgenology, 195(3), W221–w228.PubMedCentralPubMedCrossRefGoogle Scholar
- 26.Meyer, C., Ma, B., Kunju, L. P., Davenport, M., & Piert, M. (2013). Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 40(Suppl 1), S72–S78. doi: 10.1007/s00259-013-2382-2.PubMedCrossRefGoogle Scholar
- 29.Sánchez-Lara, K., Turcott, J. G., Juárez, E., Guevara, P., Núñez-Valencia, C., Oñate-Ocaña, L. F., et al. (2012). Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutrition and Cancer, 64(4), 526–534.PubMedCrossRefGoogle Scholar
- 30.Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., et al. (2008). Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. The Lancet Oncology, 9(7), 629–635.PubMedCrossRefGoogle Scholar
- 31.Jafri, S. H., Shi, R., & Mills, G. (2013). Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer, 13, 158. doi: 10.1186/1471-2407-13-158.PubMedCentralPubMedCrossRefGoogle Scholar
- 32.Piskorz, L., Lesiak, T., Brocki, M., Klimek-Piskorz, E., Smigielski, J., Misiak, P., et al. (2011). Biochemical and functional indices of malnutrition in patients with operable, non-microcelullar lung cancer. Nutrición Hospitalaria, 26(5), 1025–1032. doi: 10.1590/S0212-16112011000500016.PubMedGoogle Scholar
- 34.Chen, H., Song, Z., Qian, M., Bai, C., & Wang, X. (2012). Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. Journal of Cellular and Molecular Medicine, 16(6), 1286–1297.PubMedCentralPubMedCrossRefGoogle Scholar